Cancer

Record NHS cancer checks top three million in one year

NHS cancer checks have topped three million in a year for the first time – more than doubling in the last decade. New analysis shows that there were 3,035,698 urgent cancer referrals for patients in the last year (March 2023- Feb 2024) , compared to 1,335,350 in the same period ten years ago. (March 2013- […]

Read more

NHS staff deliver performance improvements despite record demand

The NHS exceeded its faster diagnosis cancer target for the first time in February amid record demand, according to new figures.  Thanks to the hard work of NHS staff, almost four fifths (78.1%) of people received a definitive cancer diagnosis or all clear within four weeks – with almost 200,000 (199,659) patients getting the answer […]

Read more

100,000 patients receive early access to latest cancer therapies on NHS

Almost one hundred thousand cancer patients have now benefitted from early access to the latest and most innovative treatments, thanks to the NHS Cancer Drugs Fund. The NHS is set to hit a major milestone in April with 100,000 cancer patients benefitting from faster access to more than 100 drugs (in over 250 indications) through the […]

Read more

NHS England responds to ministerial statement regarding high risk screening for some women following chest radiotherapy for Hodgkin lymphoma

The Minister of State for Health and Secondary Care has today made a written statement to Parliament regarding steps being taken by the NHS to ensure everyone eligible for the Very High Risk Breast Screening Programme has been referred to their local screening centre.   Steve Russell, NHS national director for vaccinations and screening, said: “The […]

Read more

NHS fast-tracks new therapy for rare ‘graft vs host’ disease

Cancer patients living with a rare disease which attacks the body’s own organs following a life-saving stem cell transplant are set to benefit from a pioneering new medicine on the NHS. Belumosudil (Rezurock ®) is an innovative treatment for chronic graft versus host disease, which develops in around a third of patients who have undergone […]

Read more